Suryaa Business Desk: A consortium comprising private equity firm CVC and the Belgian investment holding company Groupe Bruxelles Lambert (GBL) has successfully acquired over 90 percent of shares in the Italian pharmaceutical company Recordati. The acquisition was achieved through a tender offer in which the consortium offered 53 euros per share.
The successful completion of this deal allows for the delisting of Recordati from the stock market. The consortium is currently working to acquire the remaining minority shares in accordance with regulations to finalize the delisting process. Financial analysts suggest that moving away from public markets will allow the company to make business decisions without external pressures, supporting its long-term strategic growth and international expansion in the pharmaceutical sector. This development is considered a significant corporate reorganization within the European healthcare industry.
